Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuo Imai

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Journal of Medical Microbiology|June 26, 2019
An identification protocol for ESBL-producing Gram-negative bacteria bloodstream infections using a MinION nanopore sequencerJun Sakai, Norihito Tarumoto, Masahiro Kodana, et al.
Journal of Medical Virology|June 25, 2021
Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS® SARS-CoV-2 Antigen TestNanako Matsuzaki, Yuta Orihara, Masahiro Kodana, et al.
Infectious Disease Reports|April 26, 2024
Multicenter Study of the Effectiveness of Antifungal Stewardship Team Intervention for Candidemia in Japan in 2008-2021Mieko Tokano, Norihito Tarumoto, Jun Sakai, et al.
Journal of Medical Microbiology|October 13, 2018
Rapid identification of pathogens from positive blood culture bottles with the MinION nanopore sequencerSae Ashikawa, Norihito Tarumoto, Kazuo Imai, et al.
Journal of Pharmacological Sciences|August 4, 2022
Serum stratifin and presepsin as candidate biomarkers for early detection of COVID-19 disease progressionNoriaki Arakawa, Shinichiro Matsuyama, Masaru Matsuoka, et al.
Journal of Medical Microbiology|April 16, 2021
Clinical characteristics and antibody response to SARS-CoV-2 spike 1 protein using VITROS Anti-SARS-CoV-2 antibody tests in COVID-19 patients in JapanMayu Nagura-Ikeda, Kazuo Imai, Katsumi Kubota, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 3, 2018
First report of the isolation of bla<sub>IMI-1</sub>-producing colistin-heteroresistant Enterobacter cloacae in Japan, September 2016Norihito Tarumoto, Masahiro Kodana, Noriyuki Watanabe, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 7, 2026
Artificial Intelligence-based Gram Stain Classification: Accuracy and Clinical Utility in Positive Blood CulturesMieko Tokano, Masahiro Kodana, Norihito Tarumoto, et al.
Internal Medicine (Tokyo, Japan)|June 2, 2015
PURE-LAMP Procedure for the Diagnosis of Extrapulmonary Tuberculosis: A Case SeriesYuji Kouzaki, Kei Mikita, Takuya Maeda, et al.
Journal of Medical Virology|September 15, 2021
Evaluation of the correlation between the access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization testYutaro Kitagawa, Kazuo Imai, Masaru Matsuoka, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Journal of Medical Microbiology|June 26, 2019
An identification protocol for ESBL-producing Gram-negative bacteria bloodstream infections using a MinION nanopore sequencerJun Sakai, Norihito Tarumoto, Masahiro Kodana, et al.
Journal of Medical Virology|June 25, 2021
Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS® SARS-CoV-2 Antigen TestNanako Matsuzaki, Yuta Orihara, Masahiro Kodana, et al.
Infectious Disease Reports|April 26, 2024
Multicenter Study of the Effectiveness of Antifungal Stewardship Team Intervention for Candidemia in Japan in 2008-2021Mieko Tokano, Norihito Tarumoto, Jun Sakai, et al.
Journal of Medical Microbiology|October 13, 2018
Rapid identification of pathogens from positive blood culture bottles with the MinION nanopore sequencerSae Ashikawa, Norihito Tarumoto, Kazuo Imai, et al.
Journal of Pharmacological Sciences|August 4, 2022
Serum stratifin and presepsin as candidate biomarkers for early detection of COVID-19 disease progressionNoriaki Arakawa, Shinichiro Matsuyama, Masaru Matsuoka, et al.
Journal of Medical Microbiology|April 16, 2021
Clinical characteristics and antibody response to SARS-CoV-2 spike 1 protein using VITROS Anti-SARS-CoV-2 antibody tests in COVID-19 patients in JapanMayu Nagura-Ikeda, Kazuo Imai, Katsumi Kubota, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|May 3, 2018
First report of the isolation of bla<sub>IMI-1</sub>-producing colistin-heteroresistant Enterobacter cloacae in Japan, September 2016Norihito Tarumoto, Masahiro Kodana, Noriyuki Watanabe, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|March 7, 2026
Artificial Intelligence-based Gram Stain Classification: Accuracy and Clinical Utility in Positive Blood CulturesMieko Tokano, Masahiro Kodana, Norihito Tarumoto, et al.
Internal Medicine (Tokyo, Japan)|June 2, 2015
PURE-LAMP Procedure for the Diagnosis of Extrapulmonary Tuberculosis: A Case SeriesYuji Kouzaki, Kei Mikita, Takuya Maeda, et al.
Journal of Medical Virology|September 15, 2021
Evaluation of the correlation between the access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization testYutaro Kitagawa, Kazuo Imai, Masaru Matsuoka, et al.
Pageof 7